These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 24103111)
1. Monocytic myeloid-derived suppressor cells accumulate in renal transplant patients and mediate CD4(+) Foxp3(+) Treg expansion. Luan Y; Mosheir E; Menon MC; Wilson D; Woytovich C; Ochando J; Murphy B Am J Transplant; 2013 Dec; 13(12):3123-31. PubMed ID: 24103111 [TBL] [Abstract][Full Text] [Related]
2. Functional characterization of human Cd33+ and Cd11b+ myeloid-derived suppressor cell subsets induced from peripheral blood mononuclear cells co-cultured with a diverse set of human tumor cell lines. Lechner MG; Megiel C; Russell SM; Bingham B; Arger N; Woo T; Epstein AL J Transl Med; 2011 Jun; 9():90. PubMed ID: 21658270 [TBL] [Abstract][Full Text] [Related]
3. CD33 Sun Y; Shao J; Jiang F; Wang Y; Yan Q; Yu N; Zhang J; Zhang J; Li M; He Y Am J Reprod Immunol; 2019 Jan; 81(1):e13067. PubMed ID: 30375700 [TBL] [Abstract][Full Text] [Related]
4. Myeloid-Derived Suppressor Cells as an Immune Parameter in Patients with Concurrent Sunitinib and Stereotactic Body Radiotherapy. Chen HM; Ma G; Gildener-Leapman N; Eisenstein S; Coakley BA; Ozao J; Mandeli J; Divino C; Schwartz M; Sung M; Ferris R; Kao J; Wang LH; Pan PY; Ko EC; Chen SH Clin Cancer Res; 2015 Sep; 21(18):4073-4085. PubMed ID: 25922428 [TBL] [Abstract][Full Text] [Related]
5. Immunosuppressive role of CD11b Hyun SY; Na EJ; Jang JE; Chung H; Kim SJ; Kim JS; Kong JH; Shim KY; Lee JI; Min YH; Cheong JW Cancer Med; 2020 Oct; 9(19):7007-7017. PubMed ID: 32780544 [TBL] [Abstract][Full Text] [Related]
6. A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells. Hoechst B; Ormandy LA; Ballmaier M; Lehner F; Krüger C; Manns MP; Greten TF; Korangy F Gastroenterology; 2008 Jul; 135(1):234-43. PubMed ID: 18485901 [TBL] [Abstract][Full Text] [Related]
8. [Effect of concurrent chemoradiotherapy and radiotherapy alone on peripheral myeloid-derived suppressor and T regulatory cells in patients with nasopharyngeal cancer]. Dai XC; Liu LQ; Wang BH; Wang CM; Ma L; Cao WM; Dai EX Zhonghua Zhong Liu Za Zhi; 2017 Aug; 39(8):579-583. PubMed ID: 28835079 [No Abstract] [Full Text] [Related]
9. A circulating subpopulation of monocytic myeloid-derived suppressor cells as an independent prognostic/predictive factor in untreated non-small lung cancer patients. Vetsika EK; Koinis F; Gioulbasani M; Aggouraki D; Koutoulaki A; Skalidaki E; Mavroudis D; Georgoulias V; Kotsakis A J Immunol Res; 2014; 2014():659294. PubMed ID: 25436215 [TBL] [Abstract][Full Text] [Related]
11. Prostaglanin-E2 Potentiates the Suppressive Functions of Human Mononuclear Myeloid-Derived Suppressor Cells and Increases Their Capacity to Expand IL-10-Producing Regulatory T Cell Subsets. Tomić S; Joksimović B; Bekić M; Vasiljević M; Milanović M; Čolić M; Vučević D Front Immunol; 2019; 10():475. PubMed ID: 30936876 [TBL] [Abstract][Full Text] [Related]
12. The study of CD14+HLA-DR-/low myeloid-drived suppressor cell (MDSC) in peripheral blood of peripheral T-cell lymphoma patients and its biological function. Du J; Sun X; Song Y Cell Mol Biol (Noisy-le-grand); 2017 Mar; 63(3):62-67. PubMed ID: 28466815 [TBL] [Abstract][Full Text] [Related]
13. Surgery-induced monocytic myeloid-derived suppressor cells expand regulatory T cells in lung cancer. Wang J; Yang L; Yu L; Wang YY; Chen R; Qian J; Hong ZP; Su XS Oncotarget; 2017 Mar; 8(10):17050-17058. PubMed ID: 28178645 [TBL] [Abstract][Full Text] [Related]
14. Expansion of monocytic myeloid-derived suppressor cells in endometriosis patients: A pilot study. Chen H; Qin S; Lei A; Li X; Gao Q; Dong J; Xiao Q; Zhou J Int Immunopharmacol; 2017 Jun; 47():150-158. PubMed ID: 28407569 [TBL] [Abstract][Full Text] [Related]
19. Myeloid-derived suppressor cells induce regulatory T cells in chronically HBV infected patients with high levels of hepatitis B surface antigen and persist after antiviral therapy. Pal S; Nandi M; Dey D; Chakraborty BC; Shil A; Ghosh S; Banerjee S; Santra A; Ahammed SKM; Chowdhury A; Datta S Aliment Pharmacol Ther; 2019 May; 49(10):1346-1359. PubMed ID: 30982998 [TBL] [Abstract][Full Text] [Related]
20. Population alterations of L-arginase- and inducible nitric oxide synthase-expressed CD11b+/CD14⁻/CD15+/CD33+ myeloid-derived suppressor cells and CD8+ T lymphocytes in patients with advanced-stage non-small cell lung cancer. Liu CY; Wang YM; Wang CL; Feng PH; Ko HW; Liu YH; Wu YC; Chu Y; Chung FT; Kuo CH; Lee KY; Lin SM; Lin HC; Wang CH; Yu CT; Kuo HP J Cancer Res Clin Oncol; 2010 Jan; 136(1):35-45. PubMed ID: 19572148 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]